Cited 40 time in
Structural and Functional Properties of Activator Protein-1 in Cancer and Inflammation
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bhosale, Pritam Bhagwan | - |
| dc.contributor.author | Kim, Hun Hwan | - |
| dc.contributor.author | Abusaliya, Abuyaseer | - |
| dc.contributor.author | Vetrivel, Preethi | - |
| dc.contributor.author | Ha, Sang Eun | - |
| dc.contributor.author | Park, Min Yeong | - |
| dc.contributor.author | Lee, Ho Jeong | - |
| dc.contributor.author | Kim, Gon Sup | - |
| dc.date.accessioned | 2022-12-26T06:41:12Z | - |
| dc.date.available | 2022-12-26T06:41:12Z | - |
| dc.date.issued | 2022-05 | - |
| dc.identifier.issn | 1741-427X | - |
| dc.identifier.issn | 1741-4288 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/1260 | - |
| dc.description.abstract | The transcriptional machinery is composed of numerous factors that help to regulate gene expression in cells. The function and the fundamental role of transcription factors in different human diseases and cancer have been extensively researched. Activator protein-1 (AP-1) is an inducible transcription factor that consists of a diverse group of members including Jun, Fos, Maf, and ATF. AP-1 involves a number of processes such as proliferation, migration, and survival in cells. Dysfunctional AP-1 activity is seen in several diseases, especially cancer and inflammatory disorders. The AP-1 proteins are controlled by mitogen-activated protein kinases (MAPKs) and the NF-kappa B pathway. AP-1 inhibitors can be actively pursued as drug discovery targets in cancer therapy when used as a treatment to halt tumor progression. The consumption of phytochemicals in the diet is related to decreasing the incidence of cancer and proves to exhibit anticancer properties. Natural product targets AP-1 are effective cancer prevention and treatment options for various cancer types. Targeting AP-1 with natural products is an effective cancer treatment option for different cancer types. This review summarizes AP-1 subunit proteins, their structures, AP-1-related signaling, and its modulation by natural bioactive compounds. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Oxford University Press | - |
| dc.title | Structural and Functional Properties of Activator Protein-1 in Cancer and Inflammation | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1155/2022/9797929 | - |
| dc.identifier.scopusid | 2-s2.0-85131435815 | - |
| dc.identifier.wosid | 000807799600007 | - |
| dc.identifier.bibliographicCitation | Evidence-based Complementary and Alternative Medicine, v.2022 | - |
| dc.citation.title | Evidence-based Complementary and Alternative Medicine | - |
| dc.citation.volume | 2022 | - |
| dc.type.docType | Review | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Integrative & Complementary Medicine | - |
| dc.relation.journalWebOfScienceCategory | Integrative & Complementary Medicine | - |
| dc.subject.keywordPlus | NF-KAPPA-B | - |
| dc.subject.keywordPlus | TRANSCRIPTION FACTOR AP-1 | - |
| dc.subject.keywordPlus | C-JUN | - |
| dc.subject.keywordPlus | SIGNALING PATHWAY | - |
| dc.subject.keywordPlus | FOS | - |
| dc.subject.keywordPlus | EXPRESSION | - |
| dc.subject.keywordPlus | PROLIFERATION | - |
| dc.subject.keywordPlus | INACTIVATION | - |
| dc.subject.keywordPlus | MACROPHAGES | - |
| dc.subject.keywordPlus | INHIBITION | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
